Floatz logo

Cyclophosphamide

Fallopian Tube Carcinoma

Beijing BiotechSmall moleculePhase 2Active
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
89/ 100

Competitive context

13 Active assets in the Fallopian Tube Carcinoma cohort.

Asset / SponsorPhaseRating
Carboplatin
University of Washington
Phase 3BB
CIS-DIAMMINEDICHLOROPLATINUM II
The Netherlands Cancer Institute
Phase 3BB
Inno-206
Advenchen Laboratories, LLC
Phase 3BB
Olaparib
National Cancer Institute (NCI)
Phase 2B
(+)-VINCRISTINE
Western Regional Medical Center
Phase 2B

View all 50 →

Same molecule, other indications

Cyclophosphamide is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
mycosis fungoidesDormant
BBB
Indicative ·
78 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →